Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. 180 Life Sciences Corp shares valued at $4,700 were sold by Feldmann Marc on Dec 15 ’23. At $0.19 per share, Feldmann Marc sold 25,000 shares. The insider’s holdings dropped to 115,497 shares worth approximately $0.22 million following the completion of this transaction.
Also, Woody James N. purchased 25,000 shares, netting a total of over 4,700 in proceeds. Following the buying of shares at $0.19 each, the insider now holds 66,888 shares.
As published in their initiating research note from Maxim Group on September 15, 2021, 180 Life Sciences Corp [ATNF] has been a Buy and the price target has been revised to $11.
Analyzing ATNF Stock Performance
During the last five days, there has been a drop of approximately -10.48%. Over the course of the year, 180 Life Sciences Corp shares have dropped approximately -53.65%. Shares of the company reached a 52-week high of $17.75 on 10/16/24 and a 52-week low of $1.16 on 10/08/24. A 50-day SMA is recorded $2.80, while a 200-day SMA reached $2.26. Nevertheless, trading volume fell to 1.0 million shares from 61679.0 shares the previous day.
Support And Resistance Levels for 180 Life Sciences Corp (ATNF)
According to the 24-hour chart, there is a support level at 1.75, which, if violated, would cause prices to drop to 1.63. In the upper region, resistance lies at 2.10. The next price resistance is at 2.33. RSI (Relative Strength Index) is 34.55 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.11, which suggests the price will decrease in the coming days. Percent R is at 96.76%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
